[The immune response during combined treatment of breast cancer].
Immunological investigation was carried out in 55 breast cancer patients aged 36 to 62. Multimodality therapy included interstitial gamma-beam therapy with 60Co of the parasternal lymph nodes on the affected side, the isoeffective dose being up to 50 Gy. The major immunological indices during therapy were decreased, and 3 mos. after therapy discontinuation they partially returned to normal.
Nechushkin
M I
MI
Veskova
T K
TK
Derevnina
I A
IA
Ukrainets
A M
AM
D000328:Adult; D000917:Antibody Formation; D001918:Brachytherapy; D001943:Breast Neoplasms / Q000276:immunology* / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D008408:Mastectomy / Q000379:methods; D008875:Middle Aged; D011184:Postoperative Period; D011300:Preoperative Care; D011879:Radiotherapy Dosage; D013997:Time Factors
Immunnyĭ otvet pri kompleksnom lechenii raka molochnoĭ zhelezy.